Today’s top gainers include the company Allergan plc (NYSE:AGN) which is in the industry Drugs – Generic, gaining -1.35% today. In the last week its performance is -0.17%, and 17.13% for the past quarter. Currently, Allergan plc, AGN has a target price of 292.07, so today’s gain of -1.35% is a significant step towards its target price. The GAP today is therefore -0.40%.
Allergan plc (NYSE:AGN), has a market cap of 99016.85, and is based in USA. Insider ownership is at 0.10%, and institutional ownership is 90.90%.
At the current price of 249.61, it has a dividend yield of *TBA, and its target price is 292.07. This is with a profit margin of *TBA, and total debt/equity of 0.59. Allergan plc (NYSE:AGN) has a P/E of *TBA, as well as a forward P/E of 14.44.
With a current EPS of -5.63, and a forecasted EPS growth for next year at 23.64%,Allergan plc (NYSE:AGN) has had a EPS growth for the past five years at -50.40%. For the next five years EPS growth is projected to be 10.80%.
Performance for the year is -19.88%. Since its IPO date on 2/17/1993, the total performance to date is -19.03%.
Volume today for Allergan plc (NYSE:AGN), is 2391811, while its average volume is 3231.08. Whilst the total gain today was -1.35%, it did have a day high of -4.46%.
Volatility for this week has been at 2.06%, and 1.85% for the month. The 52-week low for Allergan plc, AGN has been 27.68%, while the 52-week-high has reached -23.20%.
Looking at its return of investments, which is -1.30%, and its return on assets is *TBA. Allergan plc (NYSE:AGN) has an operating margin of *TBA. With a sales growth of -44.20% quarter over quarter. Bearing in mind that Allergan plc, AGN is in the sector Healthcare, its long-term debt/equity is 0.53, and has a current ratio of 1 and 0.9 for quick ratio.
So what is the value of Allergan plc? Well its PEG is *TBA, and the P/S is 6.07, along with a P/B of 1.38. Meanwhile it has a p/cash of 43.55.